T3728	ER 5767 5768	3
T3729	PR:000012774 5788 5792	PIP3
T3730	PR:000023099 5970 5973	low
T3731	PR:Q90417 6015 6019	upon
T3732	PR:000022990 6121 6123	is
T3733	PR:000022182 6155 6157	by
T3734	PR:000014368 6218 6225	results
T3735	PR:000008454 6270 6285	hyperactivation
T3736	PR:000022509 6340 6342	et
T3737	PR:000022079 6364 6366	al
T3738	PR:000000364 6386 6393	Sawyers
T3739	PR:000024130 6421 6429	proposed
T3740	PR:000022478 6471 6475	dose
T3741	PR:000009791 6652 6658	levels
T3742	PR:000023552 6718 6729	qualitative
T3743	PR:000005693 6827 6833	common
T3744	PR:000010210 6874 6879	males
T3745	PR:000022990 6902 6904	in
T3746	PR:000022272 6937 6942	cases
T3747	PR:000004930 7027 7030	CaP
T3748	PR:000012085 7077 7079	of
T3749	PR:000022079 7200 7202	al
T3750	PR:000022059 7224 7227	and
T3751	PR:000029159 7269 7278	mutations
T3752	PR:000022059 7324 7327	and
T3753	PR:000022079 7430 7432	al
T3754	PR:000007655 7465 7470	focus
T3755	PR:000015619 7509 7515	system
T3756	PR:000012582 7685 7689	Pten
T3757	PR:000012582 7991 7995	Pten
T3758	PR:000022478 8223 8227	dose
T3759	PR:000012085 8382 8384	of
T3760	PR:000017021 8643 8648	under
T3761	PR:000017368 8841 8845	with
T3762	PR:000022059 9046 9049	and
T3763	PR:000007593 9200 9205	found
T3764	PR:000022959 9304 9315	hypomorphic
T3765	PR:000024065 9429 9432	the
T3766	PR:000001658 9619 9625	Ptenhy
T3767	PR:Q9W6A9 9800 9804	only
T3768	PR:000007591 9881 9882	%
T3769	PR:000022990 10014 10016	in
T3770	PR:000013439 18518 18525	Ptenpc2
T3771	PR:000013439 18593 18600	Ptenpc1
T3772	PR:000006260 18650 18659	displayed
T3773	PR:000022182 18727 18729	by
T3774	PR:000001968 18974 18984	strikingly
T3775	PR:000013439 19047 19054	Ptenpc2
T3776	PR:000022990 19219 19221	in
T3777	PR:000015938 19267 19272	shown
T3778	PR:000009791 19289 19294	local
T3779	PR:000013193 19366 19367	.
T3780	PR:000024236 19379 19383	were
T3781	PR:000004907 19458 19459	,
T3782	PR:000023361 19520 19523	not
T3783	PR:000021998 19582 19588	tumors
T3784	PR:000006719 19652 19662	disruption
T3785	PR:000000070 19805 19814	instances
T3786	PR:000005008 19867 19877	completely
T3787	PR:000004907 20128 20129	,
T3788	PR:000010229 20173 20183	moderately
T3789	PR:000004907 20297 20298	,
T3790	PR:Q90417 20357 20361	well
T3791	PR:000012582 20459 20463	Pten
T3792	PR:000004930 20535 20538	CaP
T3793	PR:000024065 20575 20578	the
T3794	PR:000000364 20636 20643	studied
T3795	PR:000022990 20774 20776	in
T3796	PR:000023458 20808 20811	old
T3797	PR:000010482 20871 20878	mutants
T3798	PR:000023266 20928 20932	more
T3799	PR:000024236 21010 21012	we
T3800	PR:000012085 21086 21088	of
T3801	1 21114 21115	-
T3802	PR:000023552 21170 21183	proliferative
T3803	PR:000004907 21307 21308	,
T3804	PR:000012733 21363 21376	proliferation
T3805	PR:000004257 23960 23967	p27Kip1
T3806	PR:000012582 23989 23993	Pten
T3807	PR:000022990 24142 24144	in
T3808	PR:000010482 24166 24173	mutants
T3809	PR:000024236 24269 24273	were
T3810	PR:000004253 24295 24302	protein
T3811	PR:000010482 24372 24379	mutants
T3812	PR:000009895 24400 24412	localization
T3813	PR:000044400 24583 24585	/−
T3814	PR:000015938 24604 24609	shown
T3815	PR:000022990 24867 24869	in
T3816	PR:000013439 24898 24905	Ptenpc2
T3817	PR:000024065 24982 24985	the
T3818	PR:000022990 25014 25016	in
T3819	PR:000004968 25324 25330	cancer
T3820	PR:000022059 25359 25362	and
T3821	PR:000012045 25537 25539	or
T3822	PR:000006300 25575 25583	distinct
T3823	PR:000022272 25670 25675	basis
T3824	PR:000011040 25700 25706	nature
T3825	PR:000007209 25867 25876	extremely
T3826	PR:000006897 25915 25923	entities
T3827	PR:000012270 26239 26251	pathological
T3828	PR:000000364 26322 26328	stages
T3829	PR:000004907 26359 26360	,
T3830	PR:000022990 26643 26645	in
T3831	PR:000024066 26665 26667	to
T3832	PR:000000021 26875 26882	outcome
T3833	PR:000022990 26895 26897	in
T3834	PR:000004257 27239 27246	p27Kip1
T3835	PR:000013543 27319 27323	PTEN
T3836	PR:000014393 27523 27532	reduction
T3837	PR:000024069 27600 27605	tumor
T3838	PR:000023266 27804 27808	more
T3839	PR:000014373 27875 27881	retain
T3840	PR:000022990 28292 28294	in
T3841	PR:000012085 28366 28368	of
T3842	PR:000012582 28604 28608	Pten
T3843	PR:000022212 28672 28675	but
T3844	PR:000022478 28753 28757	dose
T3845	PR:000022222 28851 28853	be
T3846	PR:000007449 28918 28928	facilitate
T3847	PR:000023583 29456 29464	prostate
T3848	PR:000022579 29556 29560	fact
T3849	PR:000001658 29748 29754	Ptenhy
T3850	PR:000024149 29844 29848	type
T3851	PR:000024066 29893 29895	to
T3852	PR:000022059 29977 29980	and
T3853	PR:000015699 30147 30159	specifically
T3854	PR:000005170 30254 30256	).
T3855	PR:000011579 30303 30311	observed
T3856	PR:000007209 30385 30395	expression
T3857	PR:000008477 30586 30598	heterozygous
T3858	PR:000023099 30692 30696	loss
T3859	PR:P23940 36494 36499	BamHI
T3860	PR:000013193 36701 36702	.
T3861	PR:000010220 36767 36768	(
T3862	PR:000005593 36926 36932	clones
T3863	PR:000004693 37108 37111	Bar
T3864	PR:000004481 37331 37341	transgenic
T3865	PR:Q90477 37436 37441	using
T3866	PR:000004907 37521 37522	,
T3867	PR:Q90417 37692 37696	from
T3868	PR:000003770 37926 37927	1
T3869	ER 38139 38140	3
T3870	PR:000010220 38216 38217	(
T3871	PR:000013193 38280 38281	.
T3872	PR:000016298 38437 38442	their
T3873	PR:000006884 38536 38544	embedded
T3874	PR:000011040 38616 38617	&
T3875	PR:000012582 38780 38784	Pten
T3876	PR:000017455 39006 39008	WB
T3877	PR:000029205 39332 39333	)
T3878	PR:000005506 39715 39717	25
T3879	PR:000029159 39880 39887	control
T3880	PR:000004907 40079 40080	,
T3881	PR:000010220 40265 40266	(
T3882	PR:000012085 40359 40361	of
T3883	PR:000006264 41153 41162	described
T3884	PR:000022078 41239 41244	above
T3885	PR:000024236 41286 41290	were
T3886	1 41379 41380	-
T3887	PR:000004690 41850 41861	Biosciences
T3888	PR:000022059 42134 42137	and
T3889	PR:Q06681 42228 42234	610242
T3890	PR:000023046 42386 42389	kit
T3891	PR:000003908 42482 42485	Akt
T3892	PR:000004535 42621 42624	Ab-
T3893	PR:000014700 42713 42722	performed
T3894	PR:000004968 42797 42804	carried
T3895	PR:000017519 42927 42929	67
T3896	PR:000003770 43072 43086	and polyclonal
T3897	PR:000007622 43171 43176	FOXO3
T3898	PR:000023500 43303 43305	μm
T3899	PR:000022990 43453 43455	in
T3900	PR:Q90477 43529 43534	using
T3901	PR:000029009 43658 43666	assessed
T3902	PR:000022000 43736 43737	a
T3903	PR:000010466 43896 43901	22 mm
T3904	PR:000017368 43955 43959	with
T3905	PR:000022000 44000 44001	a
T3906	PR:000024236 44066 44069	was
T3907	PR:000010287 44184 44189	14 ms
T3908	PR:000000123 44349 44356	quality
T3909	PR:000016193 44459 44471	train length
T3910	PR:000004968 44677 44687	calculated
T3911	PR:000016951 44739 44743	used
T3912	PR:000014455 44889 44897	Scardino
T3913	PR:000024050 45080 45086	the PR
T3914	PR:000004907 45349 45350	,
T3915	PR:000005908 45469 45475	and by
T3916	PR:000012582 51495 51499	Pten
T3917	PR:000012582 51649 51653	Pten
T3918	1 51676 51677	-
T3919	PR:000013050 51766 51767	/
T3920	PR:000022070 51892 51900	analysis
T3921	1 51928 51929	-
T3922	PR:Q60770 52076 52080	mTOR
T3923	PR:000007622 52103 52108	FOXO3
T3924	PR:000021999 52229 52236	showing
T3925	PR:000010220 52327 52328	(
T3926	PR:000023189 52408 52412	mice
T3927	PR:000024236 52470 52474	were
T3928	PR:000013193 52542 52543	.
T3929	PR:000006269 52584 52594	disrupting
T3930	PR:000023189 52720 52724	mice
T3931	PR:000022000 52785 52786	a
T3932	PR:000010220 52907 52908	(
T3933	PR:000024065 53013 53016	top
T3934	PR:000010220 53172 53173	(
T3935	PR:000006011 53264 53275	cytoplasmic
T3936	PR:000024236 53372 53376	weak
T3937	PR:000024004 53508 53513	shows
T3938	PR:000012085 53642 53644	of
T3939	PR:000010220 53669 53670	(
